24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
Long-Haul COVID in Kids Typically Ends Within 3 Months: StudyPfizer, Moderna Vaccines Still Offer Good Protection Against Severe COVID: StudyTrial Into Antioxidant for Parkinson's Disease Yields Disappointing ResultsIs Flu Ready for a Comeback? Get Your ShotCommon Eye Conditions Tied to Higher Risk for DementiaDrug Might Stop Heart Trouble Linked to Sickle Cell AnemiaChild Obesity Rose Sharply During PandemicFDA Advisory Panel to Meet on COVID Booster ShotsStatin Cholesterol Drugs May Help Fight Ulcerative ColitisAHA News: Physical Activity Is Helpful After a Stroke, But How Much Is Healthy?Special 'Strategies' Can Help People With Parkinson's Walk, But Many Patients UnawareEven When Undergoing Treatment, People With MS Gain From COVID VaccinesNIH Spending Nearly $470 Million on Long-Haul COVID StudyHospitalizing the Unvaccinated Has Cost U.S. Nearly $6 BillionIn 16 States, 35% or More Residents Now Obese: CDCPet Store Puppies Passing Drug-Resistant Bacteria to PeopleIs a Combo COVID/Flu Shot on the Way?1 in 500 Americans Has Died From COVID-19Having Even a Cousin or Grandparent With Colon Cancer Raises Your Risk: StudyBlood Cancer Patients Could Benefit From COVID Booster Shot: StudyWHO Says Africa Will Get 30% of COVID Vaccines It Needs by FebruaryCOVID Vaccines for Kids Under 12 Could Come This Fall: FauciEbola Vaccine Effective in African Clinical TrialBritain OK's COVID Vaccine for Kids 12 and Older; Hopes to Avoid LockdownsIsraeli Data on COVID Boosters to Be Published This Week in Major JournalData Doesn't Support Need for COVID-19 Vaccine Boosters: ExpertsCOVAX Cuts Global COVID Vaccine Supply Estimates By a QuarterMonth-Long Recovery From Concussion Is Normal: StudyDeath From COVID 11 Times More Likely If You're Unvaccinated: StudyL.A. Is First Major School District to Mandate Vaccines for Students 12 and UpNew Tally Adds Extra 16,000 U.S. Nursing Home Residents Lost to COVIDBlack Americans, Mexican Americans Develop Diabetes Earlier in LifeAverage COVID Hospitalization Is 150 Times More Expensive Than VaccinationGetting Your First COVID Shot Can Boost Mental Health: StudyVaccinated Have 1 in 13,000 Chance of Breakthrough Case Needing HospitalizationBiden Issues Tough New Vaccine Mandates Affecting Millions of U.S. WorkersTime Is Brain: Mobile Stroke Units Reduce Disability, Study FindsWildfires Cause More Than 33,000 Deaths Globally Each YearIs Your Workplace an Asthma Trigger?Biden to Strengthen Push for Vaccine Mandates in New COVID PlanAHA News: How a Simple Tape Measure May Help Predict Diabetes in Black AdultsEczema Can Take Toll on Child's Mental HealthNo Lasting Damage to Lungs After COVID in Young Patients: StudyAdults With Autism, Mental Illness May Be at Higher Risk for Severe COVIDIn Cancer Patients, COVID Vaccine Immunity at 6 Months Is Similar to General PopulationNew Insights Into Why Asthma Worsens at NightHere's How COVID-19 Can Affect Your MouthPet Dogs Can Alert Owners to Epileptic SeizuresU.S. COVID-19 Cases Now Top 40 MillionWhy Aren't COVID Vaccines Getting to People Globally?
Questions and AnswersLinks
Related Topics

Diabetes

Therapeutic Brain Implant Won't Alter Personality in Epilepsy Patients: Study


HealthDay News
Updated: Sep 7th 2021

new article illustration

TUESDAY, Sept. 7, 2021 (HealthDay News) -- Implanted brain stimulation devices used to treat epilepsy won't turn patients into someone they don't recognize, a small study shows.

"We found that the brain implants did not transform patients' sense of self or personality. Neither the long-term implantation of the electronic device in their brain, nor the electrical stimulation to modulate their brain function, led to changes in their self-perceptions -- or the perceptions of the patient by family members and others around them," said study author Tobias Haeusermann, from the University of California, San Francisco.

"This is reassuring news for more than 3,000 patients with refractory epilepsy implanted with this device to date -- as well as the many others who may consider this treatment as a way to prevent their seizures in the future," Haeusermann added.

Epilepsy causes seizures and affects around 3 million American adults. Around one-third of patients with the condition develop refractory epilepsy – which means that current medications don't work well, or at all, to stop their seizures. While brain surgery can make a difference, it isn't suitable for all patients.

Brain stimulation systems first approved in 2013 monitor and decode brain activity, and they automatically adjust treatment delivered through electrical pulses. The devices are approved in the United States to prevent seizures and other symptoms in patients with refractory epilepsy.

In this study, researchers followed 12 patients and their family caregivers over two years to assess their experiences with the devices.

The findings were published Sept. 2 online in the journal AJOB Neuroscience.

"Next-generation brain stimulation devices can modulate brain activity without human intervention, which raises new ethical and policy questions. But while there is a great deal of speculation about the potential consequences of these innovative treatments, very little is currently known about patients' experiences of any device approved for clinical use," Haeusermann said in a journal news release.

The researchers noted the brain implant used for these epilepsy patients does not have many of the more advanced functions that are envisioned for future devices.

"This issue is becoming even more pressing, as several similar treatments are currently under development for several common neurological and psychiatric conditions, including depression, anxiety chronic pain, Alzheimer's disease and ischemic stroke -- offering the promise of effective new treatments for these debilitating illnesses," he added.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more on epilepsy.

SOURCE: AJOB Neuroscience, news release, Sept. 2, 2021